Medical News

RSS

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.

7 Feb 2011

Sugary snacks and lax dental hygiene put kids at risk for tooth decay

While the most prevalent focus of February is on Valentine's sweethearts, parents are well advised to also focus on the proverbial sweet tooth - particularly when it comes to their children. That's because February is National Children's Dental Health Month, an ideal time - according to Health Net, Inc. - for moms and dads to make sure that sugary snacks, as well as lax dental hygiene - aren't putting their kids at risk for tooth decay.

7 Feb 2011

UHS announces acquisition of Emergent Group and PRI Medical

Universal Hospital Services, Inc. ("UHS"), a leading provider of medical equipment management and service solutions, today announced the signing of a definitive agreement whereby UHS will acquire Emergent Group Inc. and its wholly owned subsidiary, PRI Medical Technologies, Inc., a leading provider of mobile medical lasers and surgical equipment, for $8.46 per Emergent Group share in an all-cash transaction.

7 Feb 2011

Princeton HealthCare System awards OSI Systems $2.3M patient monitoring solutions contract

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received an approximate $2.3 million contract from Princeton HealthCare System.

7 Feb 2011

Psychiatric symptoms of bed breath

A study, published in the last 2010 issue of Psychotherapy and Psychosomatics by a group of researchers of the University of Torino (Italy), has explored the personality correlates and psychiatric symptoms of bed breath.

7 Feb 2011

FTC grants Genoptix early termination of waiting period under HSR Act for Novartis' cash tender offer

Genoptix, Inc. announced today that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act") applicable to the cash tender offer by Novartis to purchase all outstanding shares of common stock of Genoptix at USD$25.00 per share.

7 Feb 2011

Emeritus enters agreement with Columbia Pacific Advisors to manage assisted living and memory care community

Emeritus Corporation, a national provider of senior living services, announced the signing of an agreement with Columbia Pacific Advisors to manage an assisted living and memory care community. This agreement represents the third such agreement entered into between the parties since August 2010 covering three communities with 269 total units.

7 Feb 2011

Bruker launches new fully automated and fast toxin identification system

Bruker today announces the North American launch of its compact, fully automated and fast toxin identification system, called pTD™ (portable Toxin Detector), at the American Society for Microbiology (ASM) Bio-Defense and Emerging Diseases Research Meeting in Washington, DC. The novel, benchtop, push-button pTD system is intended for smaller, field and mobile laboratories for use by non-expert operators in homeland security applications.

7 Feb 2011

A.D.A.M. shareholders approve Agreement and Plan of Merger with Ebix

A.D.A.M., Inc., a leading provider of innovative online technology solutions for the health, benefits and education markets, today announced that its shareholders have approved the Agreement and Plan of Merger, dated as of August 29, 2010, by and among A.D.A.M., Ebix, Inc. ("Ebix") and Eden Acquisition Sub, Inc., a direct wholly owned subsidiary of Ebix.

7 Feb 2011

AB SCIEX, ARUP enter collaboration to develop new clinical research test methods for hormone analysis

AB SCIEX, a global leader in life science analytical technologies, today announced a collaboration with ARUP Laboratories, a major clinical reference laboratory in the United States, to develop new test methods that clinical research laboratories around the world can adopt to improve hormone analysis.

7 Feb 2011

Helix Medical to invest over $4M for new manufacturing facility in Costa Rica

Helix Medical, LLC, a global manufacturer for the medical device and healthcare industries, will soon begin construction on a new medical manufacturing facility in Costa Rica. Helix Medical signed a leasing agreement in The Coyol Free Trade Zone and Business Park in Alajuela, Costa Rica, just outside of San Jose. The company will invest more than $4M in the new plant that will soon employ more than 100 people.

7 Feb 2011

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into an exclusive worldwide (except Japan) agreement by which Salix has licensed rights to RELISTOR® (methylnaltrexone bromide).

7 Feb 2011

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2010.

7 Feb 2011

First Edition: February 7, 2011

Today's headlines focus on how states face major budget challenges -- with health policy at the heart of the issue.

7 Feb 2011

BAI releases 2011 State of AIDS in Black America report

The Black AIDS Institute ("BAI"), the only national HIV/AIDS think tank focused exclusively on the Black community in the US, today released its 2011 State of AIDS in Black America report, Deciding Moment. 2011 marks the 30th anniversary of the AIDS epidemic in America and presents unique opportunities to curtail the HIV/AIDS pandemic, but key challenges remain to moving forward in the AIDS response in Black America.

7 Feb 2011

Humana fourth quarter diluted EPS decreases to $0.63

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended December 31, 2010 (4Q10) of $0.63, compared to $1.48 per share for the quarter ended December 31, 2009 (4Q09).

7 Feb 2011

Viking Systems retains Porter, LeVay & Rose to help communicate company's key initiatives

Viking Systems, a leading worldwide developer, manufacturer and marketer of 2D and 3D visualization solutions for complex minimally invasive surgery, today announced that it has retained Porter, LeVay & Rose, Inc., to advise the Company on its investor relations initiatives.

7 Feb 2011

Proactive chronic care management can reduce hospital admission, readmission rates

Two Healthways Center for Health Research studies recently published in Population Health Management demonstrate that hospital admissions and readmissions can be reduced through chronic care management and proactive interventions, such as telephonic outreach, resulting in considerable cost savings.

7 Feb 2011

Reliv International launches new nutritional supplement to address entire fatigue cycle

Consumers who are fighting the fatigue cycle -- physical fatigue, mental fog and stress -- now have a new means of breaking that cycle. Reliv 24K, a new nutritional supplement, is the first shot to provide healthy energy and greater mental focus while also reducing stress. Reliv International, Inc., a creator of nutritional supplements that promote optimal health, introduced the product last weekend in Atlanta.

7 Feb 2011

Greenway University receives Colorado state approval to teach medical marijuana

Greenway University, the industry's leading medical marijuana educational provider, has received full formal state approval from the Colorado Department of Higher Education. Greenway University marks yet another industry milestone by moving from probationary status to full status as a recognized Colorado vocational school.

7 Feb 2011

Medical News

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

Sugary snacks and lax dental hygiene put kids at risk for tooth decay

UHS announces acquisition of Emergent Group and PRI Medical

Princeton HealthCare System awards OSI Systems $2.3M patient monitoring solutions contract

Psychiatric symptoms of bed breath

FTC grants Genoptix early termination of waiting period under HSR Act for Novartis' cash tender offer

Emeritus enters agreement with Columbia Pacific Advisors to manage assisted living and memory care community

Bruker launches new fully automated and fast toxin identification system

A.D.A.M. shareholders approve Agreement and Plan of Merger with Ebix

AB SCIEX, ARUP enter collaboration to develop new clinical research test methods for hormone analysis

Helix Medical to invest over $4M for new manufacturing facility in Costa Rica

Progenics, Salix enter exclusive worldwide license agreement for RELISTOR

AMRI fourth quarter total revenue increases 12% to $48.6 million

First Edition: February 7, 2011

BAI releases 2011 State of AIDS in Black America report

Humana fourth quarter diluted EPS decreases to $0.63

Viking Systems retains Porter, LeVay & Rose to help communicate company's key initiatives

Proactive chronic care management can reduce hospital admission, readmission rates

Reliv International launches new nutritional supplement to address entire fatigue cycle

Greenway University receives Colorado state approval to teach medical marijuana

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News